InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the detailed record of transactions filed by Magnus Christensen. Director active across 1 company, notably Cinclus Pharma Holding AB (publ). Aggregated, 1 reports have been recorded. Activity tracked since 15 May 2026. The latest transaction was filed on 15 May 2026 (Purchase). Regulator: FIN-FSA. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration